Winner Medical Co., Ltd. (SHE:300888)
China
· Delayed Price · Currency is CNY 44.35
+0.32 (0.73%)
Apr 2, 2025, 2:45 PM CST
Winner Medical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 1, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Market Capitalization | 25,640 | 21,889 | 30,011 | 35,164 | 70,798 | - | Upgrade
|
| Market Cap Growth | -22.90% | -27.06% | -14.65% | -50.33% | - | - | Upgrade
|
| Enterprise Value | 23,313 | 16,936 | 25,711 | 28,699 | 63,672 | - | Upgrade
|
| Last Close Price | 44.03 | 36.11 | 47.92 | 54.43 | 108.00 | - | Upgrade
|
| PE Ratio | - | 37.71 | 18.18 | 28.37 | 18.58 | - | Upgrade
|
| Forward PE | 30.97 | 11.53 | 18.04 | 17.13 | 28.43 | - | Upgrade
|
| PS Ratio | 3.14 | 2.67 | 2.64 | 4.38 | 5.65 | - | Upgrade
|
| PB Ratio | 2.23 | 1.81 | 2.46 | 3.29 | 6.76 | - | Upgrade
|
| P/TBV Ratio | 2.09 | 2.26 | 3.11 | 3.38 | 6.91 | - | Upgrade
|
| P/FCF Ratio | 52.08 | 70.55 | 16.82 | 273.82 | 16.88 | - | Upgrade
|
| P/OCF Ratio | 13.94 | 20.59 | 10.06 | 40.34 | 14.85 | - | Upgrade
|
| EV/Sales Ratio | 2.83 | 2.07 | 2.27 | 3.57 | 5.08 | - | Upgrade
|
| EV/EBITDA Ratio | 23.51 | 17.16 | 12.55 | 22.43 | 12.95 | - | Upgrade
|
| EV/EBIT Ratio | 54.95 | 25.01 | 14.43 | 25.79 | 13.38 | - | Upgrade
|
| EV/FCF Ratio | 47.36 | 54.59 | 14.41 | 223.48 | 15.18 | - | Upgrade
|
| Debt / Equity Ratio | 0.22 | 0.18 | 0.23 | 0.06 | 0.01 | 0.08 | Upgrade
|
| Debt / EBITDA Ratio | 2.69 | 1.80 | 1.25 | 0.40 | 0.03 | 0.37 | Upgrade
|
| Debt / FCF Ratio | 5.41 | 7.02 | 1.59 | 4.66 | 0.04 | 1.70 | Upgrade
|
| Asset Turnover | 0.45 | 0.46 | 0.72 | 0.61 | 1.43 | 1.08 | Upgrade
|
| Inventory Turnover | 2.63 | 2.94 | 4.02 | 2.93 | 4.72 | 2.44 | Upgrade
|
| Quick Ratio | 1.45 | 2.04 | 1.88 | 4.13 | 3.96 | 1.26 | Upgrade
|
| Current Ratio | 1.93 | 2.47 | 2.21 | 4.99 | 4.53 | 2.25 | Upgrade
|
| Return on Equity (ROE) | -7.55% | 5.17% | 14.63% | 11.70% | 56.08% | 18.79% | Upgrade
|
| Return on Assets (ROA) | 1.44% | 2.39% | 7.07% | 5.29% | 33.93% | 8.75% | Upgrade
|
| Return on Capital (ROIC) | 1.74% | 2.89% | 8.46% | 6.35% | 42.37% | 11.63% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.30% | 5.30% | 14.00% | 9.90% | 45.00% | 17.80% | Upgrade
|
| Earnings Yield | -3.96% | 2.65% | 5.50% | 3.52% | 5.38% | - | Upgrade
|
| FCF Yield | 1.92% | 1.42% | 5.95% | 0.36% | 5.92% | - | Upgrade
|
| Dividend Yield | 1.82% | 1.39% | 2.83% | 1.65% | 1.67% | - | Upgrade
|
| Payout Ratio | 0.00% | 141.56% | 24.29% | 61.98% | 2.69% | 7.88% | Upgrade
|
| Buyback Yield / Dilution | 0.54% | -0.10% | 0.77% | -9.42% | -3.31% | -1.14% | Upgrade
|
| Total Shareholder Return | 2.35% | 1.29% | 3.60% | -7.77% | -1.64% | -1.14% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.